Back

Predictors of reverse left ventricular remodeling with sacubitril\valsartan therapy in heart failure and reduced ejection fraction

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Avishay Grupper

Yitzhak Shamir Medical Center, Beer Yakov (Israel)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
ESC Journals
Impact of angiotensin-receptor neprilysin inhibitor on reverse cardiac remodeling in patients with heart failure with reduced ejection fraction (hfref)
4 February 2022
thumbnail
Congress Presentation
Serial artificial intelligence-enabled ECG scores predict ejection fraction improvement in heart failure reduced ejection fraction
22 November 2025
thumbnail
Congress Presentation
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
12 December 2024
thumbnail
Congress Presentation
Patient profiles in heart failure with reduced ejection fraction: prevalence, characteristics, treatments and outcomes in a real-world heart failure population
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources